Mackenzie Financial’s Usana Health Sciences USNA Stock Holding History

Mackenzie Financial’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,980	Closed	-$219K	–	1055
2020 Q2	$219K	Sell	2,980 -19,026	-86%	-$1.49M	﹤0.01%	924
2020 Q1	$1.27M	Buy	+22,006	New	+$1.53M	﹤0.01%	594
2019 Q2	–	Sell	-20,630	Closed	-$1.73M	–	1249
2019 Q1	$1.73M	Sell	20,630 -2,915	-12%	-$304K	﹤0.01%	827
2018 Q4	$2.77M	Sell	23,545 -5,175	-18%	-$598K	0.01%	642
2018 Q3	$3.46M	Buy	+28,720	New	+$3.56M	0.01%	550

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mackenzie Financial's USNA Position: Q3 2020 in Review

Mackenzie Financial sold out of Usana Health Sciences (USNA) in Q3 2020, closing a stake of 2,980 shares — an estimated $219K sold.

Mackenzie Financial first reported a position in USNA in Q3 2018 and held it in 5 quarters. The position peaked at $3.46M in Q3 2018. 192 funds tracked by Wall St. Rank hold USNA as of Q3 2020.

Mackenzie Financial reported no remaining Usana Health Sciences position as of Q3 2020 after selling out during the quarter.
Mackenzie Financial sold 2,980 Usana Health Sciences shares in Q3 2020, an estimated $219K.
Mackenzie Financial first reported a position in Usana Health Sciences in Q3 2018 and held it in 5 quarters.
Mackenzie Financial's Usana Health Sciences position peaked at $3.46M in Q3 2018.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2020.

Based on Mackenzie Financial's 13F filing for Q3 2020, filed 13 Nov 2020.